EPISODE · Feb 11, 2019 · 9 MIN
CEO Dr. Nader Pourhassan of CytoDyn Inc. (OTCQB: CYDY) - Feb '19 update
from Stock Day Media · host Stock Day Media
CEO Dr. Nader Pourhassan of CytoDyn Inc. (OTCQB: CYDY), returns to Stock Day to talk about plans to eventually move up to the NASDAQ, revolutionizing cancer treatment, and approaching revenues by 2020. Colon Cancer # humanized monoclonal antibodies # less frequent dosing # minimal side effects # protects healthy cells # treatment and prevention of HIV #Pro 140 Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy
What this episode covers
CEO Dr. Nader Pourhassan of CytoDyn Inc. (OTCQB: CYDY), returns to Stock Day to talk about plans to eventually move up to the NASDAQ, revolutionizing cancer treatment, and approaching revenues by 2020. Colon Cancer # humanized monoclonal antibodies # less frequent dosing # minimal side effects # protects healthy cells # treatment and prevention of HIV #Pro 140 Advertising Inquiries: https://redcircle.com/brands Privacy & Opt-Out: https://redcircle.com/privacy
NOW PLAYING
CEO Dr. Nader Pourhassan of CytoDyn Inc. (OTCQB: CYDY) - Feb '19 update
No transcript for this episode yet
Similar Episodes
Sep 22, 2023 ·20m
Sep 22, 2023 ·20m
Sep 22, 2023 ·27m
Sep 22, 2023 ·14m
Sep 22, 2023 ·24m
Sep 22, 2023 ·22m